Triumph Business Capital Acquires Transportation Factoring Assets of Transport Financial Solutions
DALLAS, July 08, 2020 (GLOBE NEWSWIRE) — Triumph Bancorp, Inc. (Nasdaq: TBK) (the “Company”) announced today the close of the […]
TSX News -
Enerflex to Announce Second Quarter 2020 Results on August 6, 2020
CALGARY, Alberta, July 08, 2020 (GLOBE NEWSWIRE) — Enerflex Ltd. (TSX:EFX) (“Enerflex” or the “Company”), a leading supplier of products […]
IBC Announces Appointment of Mark Smith as CEO
FRANKLIN, Ind., July 08, 2020 (GLOBE NEWSWIRE) — IBC Advanced Alloys Corp. (“IBC” or the “Company”) (TSX-V: IB; OTCQB: IAALF) […]
TSX News -
Firan Technology Group Corporation (“FTG” or “the Corporation”) Announces Second Quarter 2020 Financial Results
TORONTO, July 08, 2020 (GLOBE NEWSWIRE) — Firan Technology Group Corporation (TSX: FTG) today announced financial results for the second […]
Algonquin Power & Utilities Corp. Announces C$900 Million Offering of Common Shares Comprised of C$550 Million Bought Deal Offering and Concurrent C$350 Million Offering to an Institutional Investor
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 15, 2020 […]
TSX News -
2020 Second Quarter Results
CONFERENCE CALL AND WEBCAST FOR INVESTORS AND ANALYSTSDate: July 30, 2020Time: 1:00 p.m. (Eastern Time)EDMUNDSTON, New Brunswick, July 08, 2020 […]
DAVIDsTEA Obtains Initial Order Under Companies’ Creditors Arrangement Act
MONTREAL, July 08, 2020 (GLOBE NEWSWIRE) — DAVIDsTEA Inc. (Nasdaq:DTEA) (“DAVIDsTEA” or the “Company”), a leading tea merchant in North America, […]
The New England Journal of Medicine Publishes Final Results from Phase 1/2 Study of Tofersen for a Genetic Form of ALS
Tofersen is an investigational molecule for superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS), the second most common genetic form […]
TSX News -
Knight Therapeutics Announces CVM Approval of the Tender Offer for remaining 48.8% of Grupo Biotoscana
MONTREAL, July 08, 2020 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) and its wholly owned subsidiary 1178991 CANADA INC. […]
Dealnet Announces Rebounding Originations
TORONTO, July 08, 2020 (GLOBE NEWSWIRE) — Dealnet Capital Corp. (“Dealnet” or the “Company”) (TSX VENTURE: DLS) announced today that […]
